Pyridinone oxovanadium(IV) complexes: a new class of insulin mimetic compounds

Transition Metal Chemistry

Volumn 26, Issue 1-2, 2001, Pages 219-223

  Rangel, Maria ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; CHARACTERIZATION; COMPLEXATION; COORDINATION REACTIONS; MOLECULAR STRUCTURE; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL); TRANSITION METAL COMPOUNDS;

INSULIN MIMETIC COMPOUNDS; PYRIDINONE OXOVANADIUM; SOLVATION;

VANADIUM COMPOUNDS;

EID: 0035253235     PISSN: 03404285     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007130400129     Document Type: Article

References (41)

1. Y. Shechter and S.D.J. Karlish, Nature, 284, 556 (1980).
2. Y. Shechter and S.D.J. Karlish, Biochemistry, 20, 5795 (1981).
3. Y. Shechter and J.J. Meyerovitch, Biol. Chem., 262, 6658 (1987).
4. E.J. Underwood, Trace Elements in Human and Animal Nutrition, Academic Press, New York, 1977.
5. E. Heylieger, A.G. Tahiliani and J.H. McNeill, Science, 227, 1474 (1985).
6. H. Sakurai, K. Fujii, H. Watanabe and H. Tamura, Biochem. Biophys. Res. Commun., 214, 1095 (1995).
7. S. Fujimoto, K. Fujii, H. Yasui, R. Matsushita, J. Takada and H. Sakurai, J. Clin. Biochem. Nutr., 23, 113 (1997).
8. K. Kawabe, M. Tadokoro, Y. Kojima, Y. Fujisawa and H. Sakurai, Chem. Lett., 9 (1998).
9. R. Tawa, K. Uchida, J. Taniyama, Y. Fujisawa, S. Fujimoto, T. Nagaoka, K. Kanamori and H. Sakurai, J. Pharm. Pharmacol., 51, 119 (1999).
10. K. Kawabe, T. Suekuni, T. Inada, K. Yamato, M. Tadokoro, Y. Kojima, Y. Fujisawa and H. Sakurai, Chem. Lett., 1155 (1988).
11. K. Kawabe, M. Tadokoro, A. Ichimura, Y. Kojima, T. Takino and H. Sakurai, J. Am. Chem. Soc., 121, 7937 (1999).
12. H. Sakurai, H. Sano, T. Takino and H. Yasui, Chem. Lett., 913 (1999).
13. H. Sakurai, K. Tsuchiya, M. Nukatsuka, J. Kawada, S. Ishikawa, H. Yoshida and M. Komatsu, J. Clin. Biochem. Nutr., 8, 193 (1990).
14. H. Watanabe, M. Nakai, K. Komazawa and H. Sakurai, J. Med. Chem., 37, 876 (1994).
15. H. Sakurai, H. Watanabe, H. Tamura, H. Yasui, R. Matsushita and J. Takada, Inorg. Chim. Acta, 283, 175 (1998).
16. J.H. McNeill, V.G. Yuen, H.R. Hoveyda and C. Orvig, J. Med. Chem., 35, 1489 (1992).
17. V.G. Yuen, C. Orvig and J.H. McNeill, Can. J. Physiol. Pharmacol., 71, 263 (1993).
18. V.G. Yuen, C. Orvig, K.H. Thompson and J.H. McNeill, Can. J. Physiol. Pharmacol., 71, 270 (1993).
19. S. Dai, V.G. Yuen, C. Orvig and J.H. McNeill, Pharmacol. Commun., 3, 311 (1993).
20. H. Sakurai and A. Tsuji in J.O. Nriagu (Ed), Vanadium in the Environment, Part 2, Health Effects, John Wiley & Sons, New York, 1998, p. 297.
21. H. Sakurai, K. Fujii, S. Fujimoto, Y. Fujisawa, K. Takechi and H. Yasui in A.S. Tracey and D.C. Craus (Eds), Vanadium compounds: Chemistry, Biochemistry, and Therapeutic Applications. Acs Symp. Ser. Am. Chem. Soc., 1998, vol. 711, p. 344.
22. K.H. Thompson, J.H. McNeill and C. Orvig in N.J. Clarke and P.J. Sadler (Eds), Topics in Biological Inorganic Chemistry, Springer-Verlag, Heidelberg, 1999, vol. 2, p. 139.
23. K.H. Thompson, J.H. McNeill and C. Orvig, Chem. Rev., 99, 2561 (1999).
24. H. Sakurai, K. Tsuchiya, M. Nukatsuka, M. Sofue and J. Kawada, J. Endocrinology, 126, 451 (1990).
25. M. Nakai, W. Watanabe, C. Fujiwara, H. Kakegawa, T. Satoh, J. Takada, R. Matsushita and H. Sakurai, Biol. Pharm. Bull., 18, 719 (1995).
26. J. Burgess, B. Castro, C. Oliveira, M. Rangel and W. Schlindwein, Polyhedron, 16, 789 (1997).
27. J. Burgess, Atti Accademia Peloritana dei Pericolanti, Class. Sci. Fis. Mat. Nat., 71, 171 (1995).
28. J. Burgess, B. Castro, C. Oliveira and M. Rangel, J. Chem. Research (S), 234 (1996). J. Chem. Research (M), 1338 (1996).
29. J. Burgess, B. Castro, C. Oliveira and M. Rangel, J. Chem. Research (S), 234 (1996). J. Chem. Research (M), 1338 (1996).
30. W. Sclindwein, M. Rangel and J. Burgess, J. Synchrotron Rad., 6, 597 (1999).
31. G.J. Kontoghiorghes, Analyst, 120, 845 (1995).
32. R.C. Hider and A.D. Hall, Progr. Med. Chem., 28, 41 (1998).
33. R.C. Hider and A.D. Hall, Perspectives on Bioinorganic 1, 209 (1991).
34. P.S. Dobbin, R.C. Hider, A.D. Hall, P.D. Taylor, P. Sarpong, J.P. Porter, G. Xiao and D. van der Helm, J. Med. Chem., 36, 2448 (1993).
35. A.E. Martell, Inorganic Chemistry in Biology and Medicine, ACS Meeting No. 178, Washington, DC, 1980.
36. Z.H. Zhang, P.M. Lyster, G.A. Webb and C. Orvig, Nucl. Med. Biol., 19, 327 (1992).
37. J. Burgess, Transition Met. Chem., 18, 439 (1993).
38. M.M.C.A. Castro, C.F.G.C. Geraldes, P. Gameiro, E. Pereira, B. Castro and M. Rangel, J. Inorg. Biochem. (2000), in press.
39. Y. Sun, B.R. James, S.J. Rettig and C. Orvig, Inorg. Chem., 35, 1667 (1996).
40. G.R. Hanson, Y. Sun and C. Orvig, Inorg. Chem., 35, 6507 (1996).
41. L.F. Villas-Boas and J. Costa Pessoa in G. Wilkinson, R.D. Gillard and J.A. McCleverty (Eds), Comprehensive Coordination Chemistry, Pergamon Press, Oxford, 1987, vol. 3, p. 453.